LBRX
LBCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade C from latest DB weights. Momentum 64.2 / Value 46.4
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
64
Value
46
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $45.11
Why
Momentum64 · Δ7d -30.0
Value46 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
64
40% active weight
Current posture
7d trendSoftening
Δ7d
-30.0
Δ21d
-7.0
Value
46
60% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.0
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 64.2 / Value 46.4
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$886.11M
Beta
-
Shares Out
28.68M
P/E (TTM) · Derived
-31.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-16.05
Rev YoY
-
EPS YoY
+221.7%
Gross Margin
-
Op Margin
-
Net Debt
-$291.64M
Current Ratio
35.68
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology